Testing Atropine’s Posterior Effects

• June 12, 2026

A First Look at Phase 2 ArMaDa Data

Arshad M. Khanani, MD, FASRS, discusses phase 2 findings for OCU410, an investigational gene therapy for geographic atrophy. A phase 3 program is expected to begin later this year.

• by Arshad M. Khanani, MD, MA, FASRS

• July 15, 2026

• 2 min

CMS Proposal Would Cut Payment for Same-Day Injection Visits

The proposed Physician Fee Schedule for 2027 includes changes affecting intravitreal injections, E/M services, and physician payment.

• by Jim Gallagher, senior managing editor

• July 15, 2026

• 4 min

Glaucoma in the UK

Largest-ever UK glaucoma patient survey launches to shape future eye care services in the country

• July 16, 2026

• 3 min